Literature DB >> 10390455

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria.

E R Mathiesen1, E Hommel, H P Hansen, U M Smidt, H H Parving.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10390455      PMCID： PMC28150          DOI： 10.1136/bmj.319.7201.24

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.

Authors:  E R Mathiesen; B Feldt-Rasmussen; E Hommel; T Deckert; H H Parving
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

2.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.

Authors:  G Viberti; C E Mogensen; L C Groop; J F Pauls
Journal:  JAMA       Date:  1994-01-26       Impact factor: 56.272

3.  Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

Authors:  E R Mathiesen; E Hommel; J Giese; H H Parving
Journal:  BMJ       Date:  1991-07-13

4.  Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.

Authors:  A S Levey; J J Gassman; P M Hall; W G Walker
Journal:  J Am Soc Nephrol       Date:  1991-03       Impact factor: 10.121

5.  The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

Authors:  L M Laffel; J B McGill; D J Gans
Journal:  Am J Med       Date:  1995-11       Impact factor: 4.965
  5 in total
  38 in total

Review 1.  Treatment of coexisting diabetes and hypertension.

Authors:  N M Kaplan
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

2.  Diabetic nephropathy: evidence for renoprotection and practice.

Authors:  C E Mogensen
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

Review 3.  Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Authors:  Peter Rossing
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 4.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

Authors:  G F M Strippoli; C Bonifati; M Craig; S D Navaneethan; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 5.  Microalbuminuria in diabetes mellitus.

Authors:  Sheldon W Tobe; Philip Alan McFarlane; David Malcolm Naimark
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

Review 6.  Antihypertensive drugs and the kidney.

Authors:  Mitra K Nadim; Renee Dua; Vito M Campese
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 7.  Treatment of hypertension in diabetic patients with nephropathy.

Authors:  R Komers; S Anderson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 8.  The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.

Authors:  Kambiz Kalantarinia; Helmy M Siragy
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 9.  The natural progression of kidney injury in young type 1 diabetic patients.

Authors:  Julia M Steinke
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

10.  Long-term prevention of diabetic nephropathy: an audit.

Authors:  K J Schjoedt; H P Hansen; L Tarnow; P Rossing; H-H Parving
Journal:  Diabetologia       Date:  2008-04-03       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.